In the original article by Wu, et al., entitled “Whole-Transcriptome Analysis of CD133+CD144+ Cancer Stem Cells Derived from Human Laryngeal Squamous Cell Carcinoma Cells” [Cell Physiol Biochem 2018;47(4):1696-1710, DOI: 10.1159/000490992], there have been 3 typographical errors in the title and discussion section, where “CD44+” has been written as “CD144+”.
The correct title section of the paper and the corrections of the respective sentences in the discussion section are shown below.
The authors sincerely apologize for this mistake.
Whole-Transcriptome Analysis of CD133+CD44+ Cancer Stem Cells Derived from Human Laryngeal Squamous Cell Carcinoma Cells
Yongyan Wua,b,c,d Yuliang Zhanga,b,c,d Min Niua,b,c,d Yong Shia,b,c,d Hongliang Liua,b,c,d Dongli Yanga,b,c,d Fei Lia,b,c,d Yan Lue Yunfeng Bo Ruiping Zhangd,g Zhenyu Lid,h Hongjie Luoa,b,c,d Jiajia Cuia,b,c,d Jiangwei Sanga,b,c,d Caixia Xianga,b,c,d Wei Gaoa,b,c,d Shuxin Wena,b,c,d
aShanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer, Taiyuan, bDepartment of Otolaryngology Head & Neck Surgery, The First Hospital, Shanxi Medical University, Taiyuan, cOtolaryngology Head & Neck Surgery Research Institute, Shanxi Medical University, Taiyuan,
dThe Key Scientific and Technological Innovation Platform for Precision Diagnosis and Treatment of Head and Neck Cancer, Shanxi Province, Taiyuan, eDepartment of Otolaryngology Head & Neck Surgery, The First Hospital, Jinzhou Medical University, Jinzhou,
fDepartment of Pathology, Shanxi Cancer Hospital, Shanxi Medical University, Taiyuan, gDepartment of MRI & CT, Shanxi Cancer Hospital, Shanxi Medical University, Taiyuan, hModern Research Center for Traditional Chinese Medicine, Shanxi University, Taiyuan, China
On page 1706: “Previously, we isolated CD133+CD44+ cancer stem cells from LSCC cell lines, and functional study demonstrated stronger malignant behaviors in CD133+CD44+ LSCC stem cells than CD133+ or CD44+ LSCC stem cells, CD133-CD44- LSCC cells, and parental cells .”